<p align="left" style="line-height: 20.8px;"><span style="font-size: small; line-height: 1.6;">PALO ALTO, Calif., September 1, 2016-- Immune-Onc Therapeutics, Inc. ("Immune-Onc"), a newly formed biopharmaceutical company focused on advancing promising immuno-oncology therapeutics, announced a Series A financing of $7 million. Major investors include Fame Mount Limited and CLI Ventures. The financing will support discovery and development of novel antibodies with breakthrough potential in the area of cancer immunotherapy.</span></p>
<div> </div>